ICH Q10 describes a comprehensive Pharmaceutical Quality System (PQS) model that spans the entire product lifecycle, from pharmaceutical development through commercial manufacturing to product discontinuation. It was developed as a harmonized standard that supplements GMP requirements and integrates with the ICH Q9 Quality Risk Management framework. The guideline is intended to encourage the implementation of modern quality systems and continual improvement.
What Is the PQS?
The PQS described in ICH Q10 is built on four key elements: process performance and product quality monitoring, corrective and preventive action (CAPA), change management, and management review. These elements form a closed-loop system that drives continual improvement. The PQS applies to development, technology transfer, commercial manufacturing, and product discontinuation.
Regulatory Framework
ICH Q10 is not a regulatory requirement itself but rather a model that aligns with GMP requirements across ICH regions. Regulatory authorities reference ICH Q10 during inspections to evaluate the maturity and effectiveness of a manufacturer’s quality system. Adoption of ICH Q10 principles supports regulatory compliance while enabling operational excellence.
The Q10 Model
The PQS operates at two levels: the management responsibilities level, which establishes quality policy, quality planning, and management review, and the operational level, which executes day-to-day processes. Senior management has ultimate responsibility for the PQS and must ensure adequate resources, communication, and performance review. Quality metrics and product quality monitoring provide the data inputs for CAPA and change management decisions.
Applications
ICH Q10 applies to pharmaceutical drug substances, drug products, and some biological products. Contract manufacturers and CDMOs are expected to operate a PQS that interfaces with their customer’s system. The guideline also facilitates technology transfer by providing a consistent quality framework between sending and receiving units.
Conclusion
ICH Q10 provides a harmonized, lifecycle-based model for pharmaceutical quality that goes beyond minimum GMP compliance. Organizations that adopt its principles benefit from improved product quality, reduced regulatory risk, and enhanced operational efficiency. The PQS framework remains the international benchmark for pharmaceutical quality system maturity.
